{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:53:36Z","timestamp":1792004016921,"version":"4.4.0"},"reference-count":55,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Eur J Hosp Pharm"],"accepted":{"date-parts":[[2021,11,6]]},"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1136\/ejhpharm-2020-002604","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T05:30:10Z","timestamp":1645421410000},"page":"109-112","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":102,"title":["Antifungal drug resistance: an update"],"prefix":"10.1136","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5626-2251","authenticated-orcid":false,"given":"David W","family":"Denning","sequence":"first","affiliation":[{"name":"The University of Manchester, Manchester M13 9PL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"key":"2025090700271254000_29.2.109.1","unstructured":"World Health Organization . The selection and use of essential in vitro diagnostics - TRS 1031. WHO Technical Report Series, No. 1031, 2021 29 January, 2021. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240019102 [Accessed 12 Mar 2021]."},{"key":"2025090700271254000_29.2.109.2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3390\/antibiotics9120877","article-title":"Drug-resistant fungi: an emerging challenge threatening our limited antifungal armamentarium","volume":"9","author":"Arastehfar","year":"2020","journal-title":"Antibiotics"},{"key":"2025090700271254000_29.2.109.3","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","article-title":"Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology","volume":"21","author":"Hoenigl","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2025090700271254000_29.2.109.4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/antibiotics9060312","article-title":"Candidiasis and mechanisms of antifungal resistance","volume":"9","author":"Bhattacharya","year":"2020","journal-title":"Antibiotics"},{"key":"2025090700271254000_29.2.109.5","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1111\/1462-2920.15274","article-title":"Mechanisms of triazole resistance in Aspergillus fumigatus","volume":"22","author":"Nywening","year":"2020","journal-title":"Environ Microbiol"},{"key":"2025090700271254000_29.2.109.6","doi-asserted-by":"publisher","DOI":"10.1172\/jci124516"},{"key":"2025090700271254000_29.2.109.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008137","article-title":"Decreasing fluconazole susceptibility of clinical South African Cryptococcus neoformans isolates over a decade","volume":"14","author":"Naicker","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"2025090700271254000_29.2.109.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-041230"},{"key":"2025090700271254000_29.2.109.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.1997.tb00427.x"},{"key":"2025090700271254000_29.2.109.10","doi-asserted-by":"crossref","first-page":"e01038","DOI":"10.1128\/AAC.01038-18","article-title":"Correlation of in vitro susceptibility based on MICs and squalene epoxidase mutations with clinical response to terbinafine in patients with tinea corporis\/cruris","volume":"62","author":"Khurana","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2025090700271254000_29.2.109.11","unstructured":"EUCAST AFST . Overview of antifungal ECOFFs and clinical breakpoints for yeasts, moulds and dermatophytes using the EUCAST E.Def 7.3, E.Def 9.3 and E.Def 11.0 procedures. Available: https:\/\/www.eucast.org\/astoffungi\/clinicalbreakpointsforantifungals\/[Accessed 22 Apr 2021]."},{"key":"2025090700271254000_29.2.109.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h6079"},{"key":"2025090700271254000_29.2.109.13","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s11046-020-00455-8","article-title":"Trichophyton indotineae sp. nov.: a new highly terbinafine-resistant anthropophilic dermatophyte species","volume":"185","author":"Kano","year":"2020","journal-title":"Mycopathologia"},{"key":"2025090700271254000_29.2.109.14","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/jac\/dkaa111","article-title":"Multicentre validation of a EUCAST method for the antifungal susceptibility testing of microconidia-forming dermatophytes","volume":"75","author":"Arendrup","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2025090700271254000_29.2.109.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2009.09.002"},{"key":"2025090700271254000_29.2.109.16","doi-asserted-by":"publisher","DOI":"10.3201\/eid2607.200088"},{"key":"2025090700271254000_29.2.109.17","doi-asserted-by":"publisher","DOI":"10.3201\/eid1507.090043"},{"key":"2025090700271254000_29.2.109.18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1920497117"},{"key":"2025090700271254000_29.2.109.19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.fbr.2020.10.003","article-title":"The one health problem of azole resistance in Aspergillus fumigatus: current insights and future research agenda","volume":"34","author":"Verweij","year":"2020","journal-title":"Fungal Biol Rev"},{"key":"2025090700271254000_29.2.109.20","doi-asserted-by":"crossref","first-page":"e00066","DOI":"10.1128\/mSphere.00066-21","article-title":"Extensive genetic diversity and widespread azole resistance in greenhouse populations of Aspergillus fumigatus in Yunnan, China","volume":"6","author":"Zhou","year":"2021","journal-title":"mSphere"},{"key":"2025090700271254000_29.2.109.21","doi-asserted-by":"crossref","DOI":"10.1111\/1462-2920.15660","article-title":"Azole-resistant Aspergillus fumigatus is highly prevalent in the environment of Vietnam, with marked variability by land use type","author":"Duong","year":"2021","journal-title":"Environ Microbiol"},{"key":"2025090700271254000_29.2.109.22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/jof6040296","article-title":"Drug-resistant Aspergillus flavus is highly prevalent in the environment of Vietnam: a new challenge for the management of aspergillosis?","volume":"6","author":"Duong","year":"2020","journal-title":"J Fungi"},{"key":"2025090700271254000_29.2.109.23","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)70006-X"},{"key":"2025090700271254000_29.2.109.24","first-page":"268","article-title":"Performance of the AsperGenius\u00ae PCR assay for detecting azole resistant Aspergillus fumigatus in BAL fluids from allogeneic HSCT recipients: a prospective cohort study from Essen, West Germany","volume":"58","author":"Pelzer","year":"2020","journal-title":"Med Mycol"},{"key":"2025090700271254000_29.2.109.25","doi-asserted-by":"crossref","first-page":"e00604","DOI":"10.1128\/JCM.00604-19","article-title":"A novel broad allele-specific TaqMan real-time PCR method to detect triazole-resistant strains of Aspergillus fumigatus, even with a very low percentage of triazole-resistant cells mixed with triazole-susceptible cells","volume":"57","author":"Wang","year":"2019","journal-title":"J Clin Microbiol"},{"key":"2025090700271254000_29.2.109.26","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1093\/jac\/dkaa357","article-title":"Deciphering Aspergillus fumigatus triazole resistance in situ in respiratory specimens via pyrosequencing of cyp51A","volume":"75","author":"Novak-Frazer","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"2025090700271254000_29.2.109.27","unstructured":"World Health Organisation . Global antimicrobial resistance surveillance system (GLASS). Available: https:\/\/www.who.int\/glass\/en\/ [Accessed 22 Apr 2021]."},{"key":"2025090700271254000_29.2.109.28","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/myc.12857","article-title":"Micafungin may be safely administered as outpatient parenteral antimicrobial therapy for chronic pulmonary aspergillosis","volume":"62","author":"Otu","year":"2019","journal-title":"Mycoses"},{"key":"2025090700271254000_29.2.109.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2016.06.001"},{"key":"2025090700271254000_29.2.109.30","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3390\/jof6040262","article-title":"Rezafungin-mechanisms of action, susceptibility and resistance: similarities and differences with the other echinocandins","volume":"6","author":"Garcia-Effron","year":"2020","journal-title":"J Fungi"},{"key":"2025090700271254000_29.2.109.31","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/jof7030163","article-title":"Ibrexafungerp: a first-in-class oral triterpenoid glucan synthase inhibitor","volume":"7","author":"Jallow","year":"2021","journal-title":"J Fungi"},{"key":"2025090700271254000_29.2.109.32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/jof6030122","article-title":"Review of the novel investigational antifungal Olorofim","volume":"6","author":"Wiederhold","year":"2020","journal-title":"J Fungi"},{"key":"2025090700271254000_29.2.109.33","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3390\/jof6040239","article-title":"Fosmanogepix: a review of the first-in-class broad spectrum agent for the treatment of invasive fungal infections","volume":"6","author":"Shaw","year":"2020","journal-title":"J Fungi"},{"key":"2025090700271254000_29.2.109.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2015.06.010"},{"key":"2025090700271254000_29.2.109.35","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-014-3603-2"},{"key":"2025090700271254000_29.2.109.36","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01763-15"},{"key":"2025090700271254000_29.2.109.37","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(18)30103-8"},{"key":"2025090700271254000_29.2.109.38","doi-asserted-by":"crossref","first-page":"e01503","DOI":"10.1128\/JCM.01503-19","article-title":"Laboratory analysis of an outbreak of Candida auris in New York from 2016 to 2018: impact and lessons learned","volume":"58","author":"Zhu","year":"2020","journal-title":"J Clin Microbiol"},{"key":"2025090700271254000_29.2.109.39","doi-asserted-by":"publisher","DOI":"10.3201\/eid2509190040"},{"key":"2025090700271254000_29.2.109.40","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.3201\/eid2611.203504","article-title":"Multidrug-resistant Candida auris infections in critically ill coronavirus disease patients, India, April-July 2020","volume":"26","author":"Chowdhary","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"2025090700271254000_29.2.109.41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/jpids\/piaa152","article-title":"A cluster of neonatal infections caused by Candida auris at a large referral center in Colombia","volume":"10","author":"Alvarado-Socarras","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2025090700271254000_29.2.109.42","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00365-20"},{"key":"2025090700271254000_29.2.109.43","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw091"},{"key":"2025090700271254000_29.2.109.44","doi-asserted-by":"crossref","first-page":"e01001","DOI":"10.1128\/AAC.01001-20","article-title":"First report of candidemia clonal outbreak caused by emerging fluconazole-resistant Candida parapsilosis isolates harboring Y132F and\/or Y132F+K143R in Turkey","volume":"64","author":"Arastehfar","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2025090700271254000_29.2.109.45","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/mmy\/myaa098","article-title":"General hospital outbreak of invasive candidiasis due to azole-resistant Candida parapsilosis associated with an Erg11 Y132F mutation","volume":"59","author":"Corzo-Leon","year":"2021","journal-title":"Med Mycol"},{"key":"2025090700271254000_29.2.109.46","first-page":"3488","article-title":"Impact of a diagnostics-driven antifungal stewardship programme in a UK tertiary referral teaching hospital","volume":"73","author":"Rautemaa-Richardson","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2025090700271254000_29.2.109.47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/jof7010059","article-title":"Utility of 1,3 \u03b2-D-glucan assay for guidance in antifungal stewardship programs for oncologic patients and solid organ transplant recipients","volume":"7","author":"Machado","year":"2021","journal-title":"J Fungi"},{"key":"2025090700271254000_29.2.109.48","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s40121-020-00281-x","article-title":"Efficacy of a \"checklist\" intervention bundle on the clinical outcome of patients with candida bloodstream infections: a quasi-experimental pre-post study","volume":"9","author":"Vena","year":"2020","journal-title":"Infect Dis Ther"},{"key":"2025090700271254000_29.2.109.49","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jinf.2020.01.002","article-title":"Efficacy and safety of a comprehensive educational antimicrobial stewardship program focused on antifungal use","volume":"80","author":"Mart\u00edn-Guti\u00e9rrez","year":"2020","journal-title":"J Infect"},{"key":"2025090700271254000_29.2.109.50","doi-asserted-by":"crossref","DOI":"10.1186\/s12941-019-0323-z","article-title":"A systematic review of the impact of antifungal stewardship interventions in the United States","volume":"18","author":"Hart","year":"2019","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2025090700271254000_29.2.109.51","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s15010-018-01264-4","article-title":"Appropriate use of antifungals: impact of an antifungal stewardship program on the clinical outcome of candidaemia in a French university hospital","volume":"47","author":"Benoist","year":"2019","journal-title":"Infection"},{"key":"2025090700271254000_29.2.109.52","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jiac.2019.01.015","article-title":"The effects of antifungal stewardship programs at a tertiary-care teaching hospital in Japan","volume":"25","author":"Kawaguchi","year":"2019","journal-title":"J Infect Chemother"},{"key":"2025090700271254000_29.2.109.53","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt508"},{"key":"2025090700271254000_29.2.109.54","unstructured":"Antifungal interactions database and smartphone APPs. Available: https:\/\/www.aspergillus.org.uk\/antifungal-drug-interactions\/ [Accessed 22 Apr 2021]."},{"key":"2025090700271254000_29.2.109.55","doi-asserted-by":"publisher","DOI":"10.3201\/eid2302.152042"}],"container-title":["European Journal of Hospital Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ejhpharm-2020-002604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T07:27:23Z","timestamp":1757230043000},"score":1,"resource":{"primary":{"URL":"https:\/\/ejhp.bmj.com\/lookup\/doi\/10.1136\/ejhpharm-2020-002604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":55,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,21]]},"published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1136\/ejhpharm-2020-002604"],"URL":"https:\/\/doi.org\/10.1136\/ejhpharm-2020-002604","relation":{},"ISSN":["2047-9956","2047-9964"],"issn-type":[{"value":"2047-9956","type":"print"},{"value":"2047-9964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,21]]}}}